251 related articles for article (PubMed ID: 23587870)
1. The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
Kopp RP; Marshall LM; Wang PY; Bauer DC; Barrett-Connor E; Parsons JK;
Eur Urol; 2013 Oct; 64(4):672-9. PubMed ID: 23587870
[TBL] [Abstract][Full Text] [Related]
2. Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
Griebling TL
J Urol; 2014 Apr; 191(4):1056. PubMed ID: 24703136
[No Abstract] [Full Text] [Related]
3. Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
Taneja SS
J Urol; 2013 Nov; 190(5):1763-4. PubMed ID: 24120777
[No Abstract] [Full Text] [Related]
4. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
[TBL] [Abstract][Full Text] [Related]
6. Psychological resilience aspects that mediate the depressive effects of urinary incontinence in prostate cancer survivors 10 years after treatment with radiation and hormone ablation.
Sharpley CF; Bitsika V; Christie DRH; Bradford R; Steigler A; Denham JW
J Psychosoc Oncol; 2017; 35(4):438-450. PubMed ID: 28318448
[TBL] [Abstract][Full Text] [Related]
7. A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy.
Dalela D; Jeong W; Prasad MA; Sood A; Abdollah F; Diaz M; Karabon P; Sammon J; Jamil M; Baize B; Simone A; Menon M
Eur Urol; 2017 Nov; 72(5):677-685. PubMed ID: 28483330
[TBL] [Abstract][Full Text] [Related]
8. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study.
Stattin P; Sandin F; Thomsen FB; Garmo H; Robinson D; Lissbrant IF; Jonsson H; Bratt O
Eur Urol; 2017 Jul; 72(1):125-134. PubMed ID: 27481175
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
10. Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery.
Steineck G; Bjartell A; Hugosson J; Axén E; Carlsson S; Stranne J; Wallerstedt A; Persson J; Wilderäng U; Thorsteinsdottir T; Gustafsson O; Lagerkvist M; Jiborn T; Haglind E; Wiklund P;
Eur Urol; 2015 Mar; 67(3):559-68. PubMed ID: 25457018
[TBL] [Abstract][Full Text] [Related]
11. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
12. Lower urinary tract symptom severity, urinary bother, and incident life-space mobility restriction among older men.
Bauer SR; Le T; Ensrud KE; Cawthon PM; Newman JC; Suskind AM; Covinsky K; Marshall LM;
J Am Geriatr Soc; 2023 Apr; 71(4):1093-1104. PubMed ID: 36522685
[TBL] [Abstract][Full Text] [Related]
13. Population-based study of long-term functional outcomes after prostate cancer treatment.
Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
[TBL] [Abstract][Full Text] [Related]
14. Lower Urinary Tract Symptoms and Urinary Bother Are Common in Patients Undergoing Elective Cervical Spine Surgery.
Lieberman EG; Radoslovich S; Marshall LM; Yoo JU
Clin Orthop Relat Res; 2019 Apr; 477(4):872-878. PubMed ID: 30844824
[TBL] [Abstract][Full Text] [Related]
15. Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.
Parsons JK; Messer K; White M; Barrett-Connor E; Bauer DC; Marshall LM;
Eur Urol; 2011 Dec; 60(6):1173-80. PubMed ID: 21802828
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
17. Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
Keating NL; O'Malley AJ; Freedland SJ; Smith MR
Eur Urol; 2013 Jul; 64(1):159-66. PubMed ID: 22537796
[TBL] [Abstract][Full Text] [Related]
18. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
[TBL] [Abstract][Full Text] [Related]
20. Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer.
O'Farrell S; Garmo H; Holmberg L; Adolfsson J; Stattin P; Van Hemelrijck M
J Clin Oncol; 2015 Apr; 33(11):1243-51. PubMed ID: 25732167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
